Now, Nitraflex is even better than before
FDA has approved LEROCHOL (lerodalcibep-liga), a novel third-generation PCSK9 inhibitor from LIB Therapeutics, for adults with elevated LDL cholesteroladding a differentiated option to the lipid-lowering biologics market
Avoid highly processed foods and sugary snacks to maximize the benefits
Clinical trials show that respiratory symptoms are not typical direct effects of the medication itself, though weight loss-related changes in the body can sometimes affect breathing patterns
Understanding your genetic predispositions and baseline biomarkers can support a more informed conversation with your provider about whether compounded or branded semaglutide aligns with your clinical needs, treatment goals, and access situation
Semaglutide is among the newer anti-diabetes agents that have also proved unexpectedly helpful in weight management